VivoSeq
Neurology

Neuromuscular Blockade

0

Pipeline Programs↗

8

Active Trials↗

1

Companies Involved↗

Neuromuscular Blockade is an early-stage landscape with 0 programs across 1 company. The most active players are Merck & Co..

Intelligence

Pipeline Metrics

Competitive Density

24/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

96/100

Attrition Rate

2/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Merck & Co. logo

Merck & Co.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

83

clinical trials

Completed53 · 64%
Unknown status20 · 24%
Recruiting4 · 5%
Not yet recruiting2 · 2%
Active, not recruiting2 · 2%
Terminated1 · 1%
Other1 · 1%

Clinical Trials

Trial Activity

83 trials

The Clinical Effect of Sugammadex Sodium (Domestic) for Antagonizing Neuromuscular Blockade After Thoracic Surgery
Recruiting·TThe Fourth Affiliated Hospital of Zhejiang University School of Medicine·N/A·NCT06334562·80 enrolled
Neuromuscular Blockade Comparison for GI-2 Recovery After Bowel Resection
Recruiting·UUniversity of California, Irvine·Phase 4·NCT06112353·128 enrolled
Deep Neuromuscular Blockade on Postoperative Pain
Recruiting·SSeoul National University Hospital·N/A·NCT06679569·106 enrolled
Recovery Times of Half Dose Sugammadex and Neostigmine for Rocuronium-induced Neuromuscular Blockade
Recruiting·UUniversitas Padjadjaran·Phase 1/2·NCT06794450·60 enrolled
Reversal of Neuromuscular Blockade During the General Anaesthesia
Active, not recruiting·TTampere University Hospital·N/A·NCT04048655·120 enrolled
Reversal of Pipecuronium-induced Neuromuscular Blockade With Sugammadex During Propofol Anesthesia
Active, not recruiting·TTamas Vegh, MD·Phase 4·NCT07044180·80 enrolled
Reversal of Pipecuronium-induced Neuromuscular Blockade With Sugammadex During Sevoflurane Anesthesia
Not yet recruiting·TTamas Vegh, MD·Phase 4·NCT07044193·80 enrolled
Deep Versus Moderate Neuromuscular Blockade in Bariatric Surgery
Not yet recruiting·UUniversity Hospital of Patras·N/A·NCT06553066·50 enrolled
Magnesium Sulfate Effect Following the Reversal of Neuromuscular Blockade Induced by Rocuronium With Sugammadex
Completed·UUniversidade Federal do Rio de Janeiro·Phase 4·NCT02932254·60 enrolled
Sugammadex Dosage Based on Ideal Body Weight for Profound Rocuronium-induced Neuromuscular Blockade Reversal in Morbidly Obese Patients
Completed·PPoitiers University Hospital·Phase 2·NCT02545595
Recovery of Diaphragmatic Function After Neuromuscular Blockade and Sugammadex
Completed·UUniversity Hospital, Antwerp·Phase 3·NCT01962298·75 enrolled
Influence of Deep Versus Moderate Neuromuscular Blockade During General Anesthesia on 30-day Readmission Rates
Completed·LLeiden University Medical Center·N/A·NCT03174223·460 enrolled
Electromyographic Activity of the Respiratory Muscles During Neostigmine or Sugammadex Enhanced Recovery After Neuromuscular Blockade
Completed·OOnze Lieve Vrouw Hospital·Phase 4·NCT02403063·18 enrolled
Depth of Neuromuscular Blockade and the Perioperative Conditions in Laparoscopic Surgery in Pediatric Population
Completed·—·N/A·NCT02546843·66 enrolled
Reversal With Sugammadex From Deep Neuromuscular Blockade Induced by Rocuronium in Children: Randomised Clinical Trial
Completed·FFundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia·Phase 3·NCT01809886·100 enrolled
Page 1 of 6

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)